The sNDA for sevabertinib is supported by data from the SOHO-01 trial, showing a median duration of response of 11.0 months and a 71% objective response rate in patients with HER2-mutated NSCLC who ...

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common complication of small cell lung cancer (SCLC). It can cause many symptoms related to low sodium or other electrolyte ...

WAUSAU, Wis. (WSAW) - In the past, being diagnosed with small-cell lung cancer seemed to be a death sentence. This type of cancer is known as one of the most aggressive and deadliest forms of cancer.

The two main categories for lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Large cell lung cancer (LCLC) is a type of NSCLC. While the conditions share some ...

SCLC diagnosis involves imaging, biopsies, and lab tests to assess tumor spread and guide treatment decisions. Treatment options vary by stage, with surgery, chemotherapy, radiation, and immunotherapy ...

COLUMBUS, Ohio — There's word of some advancements in treating one of the most aggressive and deadly types of lung cancer. Small cell lung cancer accounts for 15% of lung cancer cases and it has a ...

Is Zepzelca Right for Me? To help choose the right treatment for you, your health care provider will consider what type of lung cancer you have, the treatments you have received, and whether the ...

A team of researchers from the Keck School of Medicine of USC, the USC Alfred E. Mann School of Pharmacy and Pharmaceutical ...

The Lung Cancer Research Foundation, in partnership with patients, survivors, caregivers, loved ones, industry partners and ...